title: Comparison between observation policy and fractionated stereotactic radiotherapy (SRT) as an initial management for vestibular schwannoma.
abstract: OBJECTIVE
  To compare the use of an observation policy with that of stereotactic radiotherapy (SRT) for treatment of vestibular schwannoma.
  
  
  METHODS
  The study group consisted of 27 patients who underwent observation as an initial treatment (observation group) and 50 who received SRT (SRT group). The mean follow-up period was 35 months and 31 months, respectively. Stereotactic radiotherapy consisted of small-field fractionated radiotherapy (36-44 Gy in 20-22 fractions over 6 weeks) with or without a subsequent 4-Gy single irradiation boost.
  
  
  RESULTS
  Actuarial tumor control rate of the SRT group was significantly better than that of the observation group (p < 0.0001). The mean growth was 3.87 mm/year in the observation group and -0.75 mm/year in the SRT group (p < 0.0001). Eleven patients (41 %) in the observation group and 1 (2 %) in the SRT group received salvage therapy (p < 0.001). There was no difference in the actuarial Gardner and Robertson's class preservation curves for 5 years after the initial presentation.
  
  
  CONCLUSIONS
  Stereotactic radiotherapy using a fractionated schedule provides a better tumor control rate and a similar rate of deterioration for hearing levels compared to an observation policy. Initial SRT may be a reasonable alternative to a wait-and-see policy.
authors.affiliation: Department of Radiology, Hokkaido University School of Medicine, Sapporo, Japan. hshirato@radi.med.hokudai.ac.jp
authors.forename: H
authors.initials: H
authors.lastname: Shirato
authors.forename: T
authors.initials: T
authors.lastname: Sakamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Sawamura
authors.forename: K
authors.initials: K
authors.lastname: Kagei
authors.forename: T
authors.initials: T
authors.lastname: Isu
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: S
authors.initials: S
authors.lastname: Fukuda
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: S
authors.initials: S
authors.lastname: Soma
authors.forename: Y
authors.initials: Y
authors.lastname: Inuyama
authors.forename: K
authors.initials: K
authors.lastname: Miyasaka
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003389:Cranial Nerve Diseases / Q000209:etiology; D019583:Dose Fractionation, Radiation; D005158:Facial Paralysis / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009464:Neuroma, Acoustic / Q000473:pathology / Q000601:surgery*; D016634:Radiosurgery / Q000009:adverse effects; D014276:Trigeminal Nerve; D014722:Vestibule, Labyrinth / Q000473:pathology / Q000601:surgery